Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001724521-25-000052
Filing Date
2025-04-22
Accepted
2025-04-22 16:09:20
Documents
20
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A rcus-20250422.htm   iXBRL DEF 14A 930721
6 rcus-20250422_g1.jpg GRAPHIC 69194
7 rcus-20250422_g2.jpg GRAPHIC 72863
8 rcus-20250422_g3.jpg GRAPHIC 126711
9 rcus-20250422_g4.jpg GRAPHIC 104159
  Complete submission text file 0001724521-25-000052.txt   2492929

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20250422.xsd EX-101.SCH 2626
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20250422_def.xml EX-101.DEF 2292
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20250422_lab.xml EX-101.LAB 2785
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20250422_pre.xml EX-101.PRE 1373
22 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20250422_htm.xml XML 149606
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38419 | Film No.: 25857818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)